Earningsreport

Q4/2023 12/31/2023 EPS -1.100 ZacksConsensus -1.580 ActVsEst 0.480 - Beat

Inovio Pharmaceuticals, Inc.  (INO) 
NASDAQ:AMEX Investor Relations: ir.inovio.com/investors/default.aspx